|
Model Number 595000-001 |
Device Problems
Device Operates Differently Than Expected (2913); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Congestive Heart Failure (1783); Hemolysis (1886); High Blood Pressure/ Hypertension (1908); Hypervolemia (2664); Test Result (2695)
|
Event Date 03/02/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
The freedom driver will be returned to syncardia for evaluation.The results of the investigation will be provided in a follow-up mdr.(b)(4) initial.
|
|
Event Description
|
The customer, a syncardia certified hospital, reported that on (b)(6) 2018, the patient was admitted to the hospital for acute, high-grade, subclinical hemolysis.Hospital personnel reported that his ldh peaked around 1700 u/l and his plasma free hemoglobin levels ranged from 20-60 mg/dl.The patient was asymptomatic upon admission but developed hemoglobinuria on (b)(6) 2018 which resolved on (b)(6) 2018.The acute hemolysis occurred in the presence of hypervolemia, hypertension and right heart failure exhibited by elevations in central venous pressure, jugular venous distention and peripheral edema.The patient also presented with renal dysfunction with a serum creatinine > 2.0 mg/dl.The patient was switched from his primary freedom driver to a companion 2 driver on (b)(6) 2018 in an attempt decrease the hemolysis by manipulating the pressures and beat rate.On (b)(6) 2018 the patient was switched to a different companion 2 driver to determine whether the second companion 2 driver would provide any improvement in hemolysis.The patient was transferred to his backup freedom driver on (b)(6) 2018 after his clinical condition improved.The acute hemolysis event resolved by (b)(6) 2018 with stable ldh levels in the 800 ui/l range and plasma free hemoglobin levels in the 5-6 mg/dl range.The patient was re-discharged supported by the freedom driver on (b)(6) 2018.The freedom driver supporting the patient at the time of readmission for acute hemolysis was used by the hospital for off-site training on march 13 and 14, 2018.The site reported that the freedom driver would be returned to syncardia at the completion of training for investigation because of the hemolysis event experienced by the patient.
|
|
Manufacturer Narrative
|
The freedom driver was returned to syncardia for evaluation.The customer-reported patient increasing hemolysis caused by a possible device malfunction was unable to be confirmed.A device malfunction could not be reproduced during investigation testing using the patient simulator because the dmc tank contains water, not blood.The driver passed all functional testing and was subjected to an additional 48 hour observation run in an attempt to observe a possible malfunction or change in performance.The driver performed as intended, and there was no evidence of a device malfunction.This issue will continue to be monitored and trended in the customer experience process.Syncardia has completed its evaluation of this complaint and is closing this file.(b)(4) follow-up report 1.
|
|
Event Description
|
The customer, a syncardia certified hospital, reported that on (b)(6) 2018, the patient was admitted to the hospital for acute, high-grade, subclinical hemolysis.Hospital personnel reported that his ldh peaked around 1700 u/l and his plasma free hemoglobin levels ranged from 20-60 mg/dl.The patient was asymptomatic upon admission but developed hemoglobinuria on (b)(6) 2018 which resolved on (b)(6) 2018.The acute hemolysis occurred in the presence of hypervolemia, hypertension and right heart failure exhibited by elevations in central venous pressure, jugular venous distention and peripheral edema.The patient also presented with renal dysfunction with a serum creatinine > 2.0 mg/dl.The patient was switched from his primary freedom driver to a companion 2 driver on (b)(6) 2018 in an attempt decrease the hemolysis by manipulating the pressures and beat rate.On (b)(6) 2018 the patient was switched to a different companion 2 driver to determine whether the second companion 2 driver would provide any improvement in hemolysis.The patient was transferred to his backup freedom driver on (b)(6) 2018 after his clinical condition improved.The acute hemolysis event resolved by (b)(6) 2018 with stable ldh levels in the 800 ui/l range and plasma free hemoglobin levels in the 5-6 mg/dl range.The patient was re-discharged supported by the freedom driver on (b)(6) 2018.The freedom driver supporting the patient at the time of readmission for acute hemolysis was used by the hospital for off-site training on march 13 and 14, 2018.The site reported that the freedom driver would be returned to syncardia at the completion of training for investigation because of the hemolysis event experienced by the patient.
|
|
Search Alerts/Recalls
|
|
|